THE ROLE OF PROBIOTICS IN LIVER CIRROSIS

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/6421

Full metadata record

DC Field	Value	Language
dc.contributor.author	Alisher M. Urinov, Ilkhom O. Otajonov ,Dilafruz B. Akhmedova .	-
dc.date.accessioned	2023-02-24T10:10:49Z	-
dc.date.available	2023-02-24T10:10:49Z	-
dc.date.issued	2023	-
dc.identifier.issn	2515-8260	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/6421	-
dc.description.abstract	The frequency of cirrhosis is about 20–40 cases per 100,000 populations, and this indicator is steadily increasing. At present, it is one of the six main causes of death at the age of 35–60 years in economically developed countries. Foreign and domestic scientists are working on the development and synthesis of new drugs of chemical and natural origin for the treatment and prevention of liver diseases of various origins, in particular liver cirrhosis. Many studies have shown an important pathogenic role in the occurrence and progression of some liver diseases with changes in the intestinal microbiota. Therefore, antibiotics, prebiotics and probiotics are an effective treatment for liver diseases, which can correct the intestinal microbiota.	en_US
dc.language.iso	en	en_US
dc.subject	liver disease probiotics liver cirrhosis treatment	en_US
dc.title	THE ROLE OF PROBIOTICS IN LIVER CIRROSIS	en_US
dc.type	Article	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
межд.EJMCM_Volume 10_Issue 3_Pages 381-387.pdf		161.48 kB	Adobe PDF	View/Open

DSpace JSPUI